Pimavanserin: Potential Treatment For Dementia-Related Psychosis

Psychosis is common across dementia types with a prevalence of 20% to 70%. Currently, no pharmacologic treatment is approved for dementia-related psychosis. Atypical antipsychotics are frequently used to treat these disorders, despite significant safety concerns. Pimavanserin, a selective 5-HT2A inv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Prev Alzheimers Dis
Main Authors: Cummings, Jeffrey, Ballard, C., Tariot, P., Owen, R., Foff, E., Youakim, J., Norton, J., Stankovic, S.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2018
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6413822/
https://ncbi.nlm.nih.gov/pubmed/30298184
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14283/jpad.2018.29
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados